Brief: Shilpa Medicare Enters Into Settlement With Celltrion
17/04/2025 13:22
April 17 (Reuters) - Celltrion Inc 068270.KS: ENTERING INTO A SETTLEMENT WITH CELLTRION SETTLEMENT FOR US$3.4 MILLION CO WILL PAY CELLTRION $ 3.4 MILLION, PAYABLE IN A STAGGERED MANNER TILL JULY 2025 Source text: ID:nBSE9MZBLd Further company coverage: 068270.KS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Shilpa Medicare
See all newsBrief: Shilpa Medicare Q2 Consol Net Profit INR 791.8 Million
Brief: Shilpa Medicare Says USFDA Conducts Surveillance Inspection At Shilpa Medicare Unit
Brief: Shilpa Medicare Receives Final SEC Approval For Oeris Marketing Authorization
India's Shilpa Medicare gains on approval for OERIS
Brief: Shilpa Medicare Initiates Voluntary Recall Of 27,923 Pemetrexed Injection Vials In Us On July 29, 2026